Delivery Order SPE2DR25D9312-SPE2DR26FGES0
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $17,746.12 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on October 30, 2025, with an ultimate completion date of November 21, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a $27,331.66 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. The award falls...
- The Defense Logistics Agency awarded a $36,160.80 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on November 12, 2025, with an ultimate completion date of December 4, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award falls under DMS...
- The Defense Logistics Agency awarded a delivery order valued at $24,084.02 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency (DLA) awarded a $15,844.75 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on November 17, 2025, with an ultimate completion date of December 9, 2025, represents a discrete pharmaceutical supply requirement under DMS Pharmaceutical Group's broader prime vendor contract. No small business...
- The Defense Logistics Agency awarded a $17,746.12 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract, with an ultimate completion date of November 19, 2025, was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group Inc. serves as a...
- The Defense Logistics Agency awarded a $30.5K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The delivery order, issued on November 14, 2025, with an ultimate completion date of December 8, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued...
- The Defense Logistics Agency awarded a $18,084.06 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Prolastin C 1,000 mg/20 ml vials. The contract, designated as delivery order 4570062658, carries an ultimate completion date of December 9, 2025, and was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal...
- On January 12, 2026, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $22,546.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order, which has an ultimate completion date of February 3, 2026, is for Prolastin C 1,000 mg/20 ml vials, a specialty pharmaceutical product. This award was issued without a set-aside designation, reflecting DMS Pharmaceutical Group's...
- The Defense Logistics Agency issued a delivery order valued at $36,097.97 to DMS Pharmaceutical Group Inc. for Prolastin C 1,000 mg/20 ml vials. This firm fixed-price delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, represents a standalone pharmaceutical supply procurement with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected to...
- SPE2DR25D9312Indefinite Delivery Contract
- SPE2DR25D9312-SPE2DR26FGES0Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $15,063.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Prolastin C 1,000 mg/20 ml vials. The award, issued on January 15, 2026, with an ultimate completion date of February 6, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded on November 13, 2025, with a $499.999 billion ceiling value and completion date of December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy through which the Defense Logistics Agency establishes regional prime vendor contractors to supply pharmaceutical products and medical consumables to military healthcare facilities worldwide. Under this framework, DMS Pharmaceutical Group is authorized to fulfill firm fixed-price delivery orders for branded and generic prescription drugs, biologics, vaccines, and specialized pharmaceutical products supporting Department of Defense medical operations. The contractor's product portfolio includes oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals, positioning it as a critical supplier within the federal pharmaceutical supply chain for military healthcare operations globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.1k | 1/14/26 |